Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11) (remove)
Year of publication
- 2019 (11) (remove)
Document Type
- Journal article (10)
- Preprint (1)
Language
- English (11) (remove)
Keywords
- apoptosis (3)
- leukemic cells (3)
- cytotoxicity (2)
- Aspergillus fumigalus (1)
- Berberine (1)
- C-60 fullerene (1)
- C60 fullerene (1)
- C\(_{60}\) fullerene (1)
- Chlamydia trachomatis (1)
- Computer modelling (1)
- Cushing’s disease (1)
- DLS and AFM measurements (1)
- Doxorubicin (1)
- E8 symmetry (1)
- ERK signaling (1)
- Embryonic induction (1)
- HeLa cells (1)
- Hurwitz theorem (1)
- Lee Smolin (1)
- RNAi (1)
- UV–Vis (1)
- accumulation (1)
- boolean modeling (1)
- cancer therapy (1)
- cisplatin (1)
- cosmology (1)
- crystal growth (1)
- crystallization (1)
- dendritic cells (1)
- deubiquitinases (1)
- doxorubicin (1)
- drug release (1)
- efficient intervention points (1)
- elementary body (1)
- eugenol (1)
- evolution (1)
- heuristics (1)
- human xenografted mouse models (1)
- infection (1)
- infection biology (1)
- inflation (1)
- metabolic flux (1)
- metabolic modeling (1)
- metabolic modelling (1)
- nanocomplex (1)
- noncovalent complex (1)
- noncovalent nanocomplex (1)
- oncolytic virus (1)
- optimal drug combination (1)
- optimal drug targeting (1)
- optimal pharmacological modulation (1)
- optimal treatment strategies (1)
- pathogenesis (1)
- photodynamic chemotherapy (1)
- radiation (1)
- reticulate body (1)
- signalling (1)
- somatic mutations (1)
- synergistic effect (1)
- uptake (1)
Metabolic adaptation to the host cell is important for obligate intracellular pathogens such as Chlamydia trachomatis (Ct). Here we infer the flux differences for Ct from proteome and qRT-PCR data by comprehensive pathway modeling. We compare the comparatively inert infectious elementary body (EB) and the active replicative reticulate body (RB) systematically using a genome-scale metabolic model with 321 metabolites and 277 reactions. This did yield 84 extreme pathways based on a published proteomics dataset at three different time points of infection. Validation of predictions was done by quantitative RT-PCR of enzyme mRNA expression at three time points. Ct’s major active pathways are glycolysis, gluconeogenesis, glycerol-phospholipid (GPL) biosynthesis (support from host acetyl-CoA) and pentose phosphate pathway (PPP), while its incomplete TCA and fatty acid biosynthesis are less active. The modeled metabolic pathways are much more active in RB than in EB. Our in silico model suggests that EB and RB utilize folate to generate NAD(P)H using independent pathways. The only low metabolic flux inferred for EB involves mainly carbohydrate metabolism. RB utilizes energy -rich compounds to generate ATP in nucleic acid metabolism. Validation data for the modeling include proteomics experiments (model basis) as well as qRT-PCR confirmation of selected metabolic enzyme mRNA expression differences. The metabolic modeling is made fully available here. Its detailed insights and models on Ct metabolic adaptations during infection are a useful modeling basis for future studies.